Difference between revisions of "CFAP58-DT"

From LncRNAWiki
Jump to: navigation, search
(Name)
 
Line 7: Line 7:
 
Approved name:CFAP58 divergent transcript
 
Approved name:CFAP58 divergent transcript
  
HGNC ID:HGNC:45243
+
HGNC ID:45243
  
 
Previous names:CCDC147 antisense RNA 1|CCDC147 antisense RNA 1 (head to head)|CFAP58 antisense RNA 1 (head to head)
 
Previous names:CCDC147 antisense RNA 1|CCDC147 antisense RNA 1 (head to head)|CFAP58 antisense RNA 1 (head to head)

Latest revision as of 10:30, 19 February 2021

lncRNA CFAP58-DT orchestrates signal transduction for interferon (IFN) production and illustrates the essential role of lncRNAs in virus elimination.

Annotated Information

Name

Approved symbol:CFAP58-DT

Approved name:CFAP58 divergent transcript

HGNC ID:45243

Previous names:CCDC147 antisense RNA 1|CCDC147 antisense RNA 1 (head to head)|CFAP58 antisense RNA 1 (head to head)

Alias symbols:lncITPRIP-1

RefSeq ID:NR_108036

prev_symbol:CCDC147-AS1|CFAP58-AS1

Characteristics

The human lncRNA gene CFAP58-DT (ENSG00000231233.1, Chr10:106111349-106113333 [1.9 kbp], LNCipedia transcript ID:lnc-ITPRIP-1:1,795 nucleotides) is located on chromosome 10, adjacent to the coding gene DANGER (also named as ITPRIP) [1].

Function

lncRNA CFAP58-DT is involved in viral infection and plays a crucial role in the virus-triggered IFN signaling pathway through the targeting of melanoma differentiation-associated gene 5 (MDA5). CFAP58-DT can be induced by viral infection, which is not entirely dependent on the IFN signal [1]. MDA5 can suppress hepatitis C virus (HCV) replication independently of IFN signaling through its C-terminal-deficient domain bound to viral RNA, in which CFAP58-DT plays a role as an assistant. Data suggests that CFAP58-DTenhances the innate immune response to viral infection through the promotion of oligomerization and activation of MDA5. CFAP58-DT is involved in MDA5 activation [1].

Regulation

Please input information here.

Diseases

  • Viral infection (Hepatitis C) [1]

Expression

The expression of CFAP58-DT is highly consistent with MDA5 expression, indicating that CFAP58-DT may function as a cofactor of MDA5 [1].

Experiment Forward primer Reverse primer
Semi RT-PCR 5'-GGGGTACCGGGCAGATGGAGACACCCA- 3' 5'-CGGGATCCTGGGTTGTTGGAAAATTTGCTCAC- 3'[1]

Labs working on this lncRNA

  • Institute of Pathogen Biology and Immunology of College of Biology, State Key Laboratory of Chemo/Biosensing and Chemometrics, Hunan University, Changsha, China. [1]
  • Xiangya School of Public Health, Central South University, Changsha, Hunan, China. [1]
  • Research Center of Cancer Prevention & Treatment, Translational Medicine Research Center of Liver Cancer, Hunan Provincial Tumor Hospital, Changsha, China. [1]

References

  1. 1.0 1.1 1.2 1.3 1.4 1.5 1.6 1.7 1.8 Xie Q, Chen S, Tian R, Huang X, Deng R, Xue B, Qin Y, Xu Y, Wang J, Guo M, Chen J. LncITPRIP-1 Positively Regulates Innate Immune Response through Promoting Oligomerization and Activation of MDA5. Journal of virology. 2018.

Sequence

>gi|100505869|ref|NR_108036.1| Homo sapiens CFAP58 divergent transcript (CFAP58-DT), long non-coding RNA

000001 GGGCAGATGG AGACACCCAG GAGAAAGAAG AGGGCGAATT GGAAGAGGCC ACCCAGAAAG GACGGTGTGT GACACTAGGG 000080
000081 AGCCAAGCAT GGAGAGCCGA GGACTAACGC TTGGAAGGAA ATGTGGACCA GAAGGTTCCG GATGAGGGAA GGACTGGCGG 000160
000161 CTACACTCTG CCTTCCGAGA CAACGAGGAA TAATCTCACT TCAGTCAGTT CAACCCTTGT AAAACAGCTA CTGTGTGCAA 000240
000241 GACACGGAGG GAAAGCTGAA GTAGAGAAAC CACAGACGCT GTCTTCAAAG GGTTTAATCT AATATTAGTG ATGAGAAAAA 000320
000321 TAGGGTGCAG AGCTTAAGGC ATCCTGGAAA AACGTATGTA GCGCCACATC GCGAAAATCT CTCTTCTGGG ACCCCTCTCC 000400
000401 CAAAAACGTT TCTTCGCCCT CTTCTCCCCC TTCTGCCTCC ACTCTTTCTG GACTTCAGAT ATCTTTGAGA AGCCTGGACA 000480
000481 TCAATCTGCT TTAGAAGACT AGAAACTCTG CCTTTATGTC TTTAAGGGAA CAATAGTCCT TAACTTTGAT ACTGTGGCTC 000560
000561 TTTAGCTCTT TTTTTCCCTA TATTTTTTAT ATAGTTTTTT GGTATTATTT AGACCTCCTT AACCCCACGG TCATAAAGGT 000640
000641 ATTCTCCCAT CATTTTTTTC TATCCATTAG CTTCATAGTT TTACTTTTTT ACATTCAGTT ATCTAATCCA TCTGGAGTTC 000720
000721 TCCTTCCCAT ATGGTGTGAG ATAGGGATCT AACTATATTT TTCTCCATGG GGTGAGCAAA TTTTCCAACA ACCCATGTCA 000800
000801 AACAATCCAT TCTTTCCAAA TTGGTTTGGG GAAGTTTCCA AATAGACATG AGTATGTTCT GAGCTCTCTG GTTTGTTCAT 000880
000881 GTGTCAGTAC CACAAGGTTT TGTCACTGTG GGTTTTTAGT TAGTCATCAT GCTTGAAGGG CAAGTTCCCC ATTCCAAATT 000960
000961 CTTCTGTGTT AAGATTGCTT TGTCTATCCA CGGGCCTTTA TCCTCCCTTA TAATGTTTAG AGTAAGTTTG TCAAGTTTAT 001040
001041 GAGAACTGTG TTGGGTTGAT GAATAAATGC AAGGAAAACT GGCAA